Background/Aims: The relationship between carotid artery plaque burden, phenotype and serum cystatin C at normal and impaired renal function is still unclear. Methods: Demographic characteristics, carotid ultrasonography and other relevant information of 1,477 patients were collected. The association of carotid artery plaque burden, plaque phenotype with serum cystatin C was evaluated by strategy analysis based on renal function. Results: Serum cystatin C (OR=2.05, 95% CI: 1.83-2.29, P<.01) was a risk factor of stable plaque among patients with normal glomerular filtration rate. However, in the patients with mild impaired renal function, serum cystatin C was not only a risk factor for stable plaque (OR=1.60, 95%CI: 1.43-1.78, P<.001) but also was a risk factor for unstable plaque (OR=1.21, 95%CI: 1.10-1.32, P<.001). The smoothing function curve and a three-piecewise linear regression revealed that a nonlinear relationship was observed between serum cystatin C and plaque burden. When serum cystatin C was in the range of 0.75-1.30 (mg/L), the plaque burden tended to increase. Conclusion: In normal renal function, serum cystatin C may confer stability of plaques. In mildly impaired renal function, serum cystatin C is a risk predictor of plaques. In normal renal function circumstances, serum cystatin C may benefit to the stability of plaques. In mild impaired renal function circumstances, serum cystatin C are a risk predictors of plaques.
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Introduction
Atherosclerosis (AS) is a disease characterized by chronic inflammation in large-and medium-sized arteries. Carotid atherosclerosis (CAS) is not only an early manifestation of systemic AS but also the early phase reaction of cardiovascular diseases (CVD) [1] . Carotid artery plaque burden and plaque phenotype are two main indicators of generalized AS [2, 3] , and relate to greater risks of cardiovascular and all-cause mortality [4, 5] . Presence of atherosclerotic plaques in the internal carotid artery is associated with an increased risk of incident stroke even in asymptomatic adults aged 65 years or older [6] .
A large number of prospective studies suggest that metabolic syndrome, smoking and alcohol drinking are major risk factors of CAS [7] [8] [9] , and increase CVD morbidity and mortality in the general population [10, 11] . Recent studies found that in addition to the above risk factors, the elevated serum cystatin C (cys C) was an independent predictor of adverse cardiovascular outcomes among patients without established chronic kidney disease [12] . Cys C, which is produced by all nucleated cells, belongs tothe cystatin superfamily of endogenous cysteine protease inhibitors and could inhibit the protease of cathepsin. Cys C has recently been suggested as a more reliable marker of renal function compared to serum creatinine and blood urea nitrogen [13, 14] . Our previous studies found that Cys C, an alternative measure of renal function, had a stronger impact on carotid thickening and plaque formation than other measures of renal function [15, 16] . CAS is an inflammatory disease characterizing by extracellular matrix (ECM) remodeling (formation and degradation) in vascular wall. The dynamic balance of formation and degradation in ECM plays a key role in the development and progression of CAS [17] . Cys C can inhibit the activity of cathepsin and the degradation of ECM in the progression of atherosclerosis [18] . Unfortunately, in recent years, findings in terms of the effect of Cys C onCVD remained controversial. Muntner et al. found that a graded association existed between higher serum Cys C and increased CVD prevalence in patients without established chronic kidney disease [19] . However, Doganer et al found that lower Cys C levels were associated with increased severity of coronary artery disease [20] . Furthermore, previous studies failed to take into accountthe effect of renal function on Cys C levels. Therefore the aims of this study were to examine the relationship between Cys C and carotid artery disease stratified by varying levels of renal function, and thereby provide informative guidance in preventing severe cardiovascular and cerebrovascular events.
Materials and Methods

Study population
A total of 1,477 patients have been recruited in the Department of Medical Ultrasonics in Ma'anshan People's Hospital, China from December 2013 to June 2014. The inclusion criteria were: (a) age from 40 to 75 years; (b) without severe cardiovascular diseases; (c) creatinine derived glomerular filtration rate (GFR) ≥ 60 ml/min/1.73m 2 ; (d) without stroke history; (e) without carotid intervention history; (f) without severe infection and (g) tumor history. Informed consents were obtained from all participants (The medical ethics committee of Ma'anshan People's Hospital, No. 2014002). The sample was divided into two groups based on patients' renal function levels: normal renal function (n=900) and mild impaired renal function (n=577), while three subgroups (control group, stable plaque group, and unstable plaque group) were categorized within each group according to the results of carotid ultrasonography analysis. Thus among patients who had normal renal function, 381 were in the control group, and 242 patients and 277 patients were in the stable plaque and unstable plaque groups, respectively. Among patients who were classified as mild impaired renal function, the subsamples assigned in the control/stable plaque/unstable plaque groups were 279, 119, and 179, respectively.
Variables
The questionnaire was designed by clinical experts and experienced epidemiologists and covered multiple components, including demographic characteristics (age and sex), behaviors characteristics and body examination., Behavior characteristics include smoking (regular smoking: smoking≥1 cigarette/day, time of smoking duration≥ 6 months; occasional smoking: smoking≥4 times/week, but <1 cigarette/day or never smoking), drinking (currently drinkers: 56° alcohol liquor≥50 ml/day, >5 times/week; occasional drinkers: 56° alcohol liquor< 50 ml/day, ≤4 times/week or never drinker), and physical exercise (regularly exercise: exercise ≥ 30 min/ time, 3-7 times/week; occasional: exercise <30 min/ time, <3 times/week or never). The body examination includes height, weight, body mass index (BMI, calculated as: weight (kg)/ square of height (m 2 )). blood pressure, fasting blood glucose. Hypertension was defined as systolic blood pressure (SBP) ≥ 140 mm Hg and/or diastolic blood pressure (DBP)≥ 90 mm Hg and/or treated hypertension. Patients with fasting blood glucose > 7.1 mmol/L or treated diabetes were classified as diabetes.
Laboratory assay
For each patient who had fasted for 12 hours, a 5-7 ml venous blood was draw and then centrifuged and stored at −70℃ until assayed. Serum Cys C was determined by immunoturbidimetric assay (Inter-assay and intra-assay coefficients of variation were <3.6% and <2.7%, respectively). Fasting blood glucose was determined by glucose oxidase method, serum total cholesterol (TC) and triglyceride (TG) were determined by CHOD-PAP, high-density lipoprotein (HDL) was determined by phosphotungstic acid-magnesium precipitation, low-density lipoprotein(LDL) was determined by selective removal method. The serum creatinine (Cr) was analyzed using the Jaffe method, and traceable to the International Standardization with isotope dilution mass spectometry (IDMS). Estimated glomerular filtration rate (GFR) was calculated by Modification of diet in renal disease (MDRD) formula as follows: eGFR (ml/ min/ 1.73 m [21] . All biochemistry assays were performed with the automatic biochemical analyzer (DPP-800, Roche, Germany) by professional laboratory technician in hospital.
Carotid Ultrasonography
The near and far walls of the common carotid, the internal carotid, bifurcation, and internal carotid artery on both sides were scanned to examine the presence (yes/no) of atherosclerotic plaques using 5-13MHz linear-array probes (Aloka-а7 and Aloka-а10, Japan; Philips-IU22, America) [5] .
Patients were examined in the supine position with the head turned 45° from the side being scanned. Each carotid system was scanned in anterior oblique, lateral, and posterior oblique planes. Near and far walls of the common carotid artery began just above the clavicle and was moved cephalad through the bifurcation and along both the internal and external branches as far distally as possible. The sonographer consistently aimed for the clearest image of the far wall of the carotid artery so as to be certain that the chord of greatest length was achieved, and therefore that the image represented the true diameter of the vessel. The carotid intima media thickness (IMT) protocol consisted of scanning the carotid arteries longitudinally in the 3 segments, using the lateral extent of each carotid segment as defined relative to the tip of the flow divider, which is normally the most clearly defined anatomic reference in the proximity of the carotid bifurcation. The carotid segments were defined as follows: (1) near and far wall of the segment extending from 10 to 20 mm proximal to the tip of the flow divider into the common carotid artery; (2) near and far wall of the carotid bifurcation beginning at the tip of the flow divider and extending 10 mm proximal to the flow divider tip; and (3) near and far wall of the proximal 10 mm of the internal carotid artery. Fine transducer angulations were used to clearly display both the blood-intima and media-adventitia boundaries on both the near and far walls of the artery, and the transducer was moved toward the mandible until the lumen area increased with the appearance of the carotid bifurcation, and finally the internal carotid artery was visualized. The focus was positioned at the 40-mm depth of the near or the far wall depending on the optimized image during scanning. In the case of plaque presence, carotid IMT was measured outside the portion of plaque.
Carotid plaque, defined as was defined as local thickening of the IMT of 50% compared to the surrounding vessel wall, an IMT ≥1.5 mm, or local thickening ≥0.5 mm (as evidenced by protrusion into the lumen and/or localized roughness with increased echogenicity) [3] , was classified by surface characteristics, echogenicity, and texture. The carotid atherosclerotic plaques were classified as stable or unstable. Stable plaques were required to have all of the following features: (a) smooth and regular surface; (b) homogeneity and uniform echo geneity or dominant echo geneity with small areas of echo lucency. Unstable plaques were required to have one or more of the following features: (a) ulceration (isolated crater >1 mm with proximal and distal lipping); (b) irregular surface; (c) presence of mobile thrombi on the plaque surface or intraluminal thrombus; (d) hypoechoic plaques ; (f) heterogeneity with substantial intraplaque echolucent areas [22] . Carotid plaque area was determined as the sum cross-sectional area of all carotid plaques (IMT ≥1.5 mm) in all carotid vessels (common, internal, and bifurcations) bilaterally. Each longitudinal plaque image was corroborated against axial images to assure accurate imaging (to reduce overestimation or underestimation of plaque size) [3] . Plaque score was calculated according to the sum of the largest thickness of each individual plaque [23] .
Statistical analysis
Descriptive statistics were showed as mean ±SD for continuous variables and frequency (%) for categorical variables. Differences in baseline characteristics between levels of renal function were compared using ANOVA and Chi-Square test. Multivariate logistic regression was used to evaluate the relationship between Cys C and carotid plaque phenotype. Other covariates included age, sex, serum LDL and HDL (sls=0.05, els =0.10). Finally, smoothing function curve and a three-piecewise linear regression were used to evaluate the relationship between serum Cys C and carotid plaque burden. All analyses were performed using SPSS 13.0.
Results
Demographic characteristics
Overall, patients with carotid plaque were more likely to be older age, have higher levels of serum Cys C, LDL, SBP, as well as higher prevalence of hypertension and diabetes, comparing to patients with no lesions. In addition, n the group of patients without established renal dysfunction, the prevalence of smokingalcohol usewere higher among patients with carotid stable plaque than those with no lesions. While within the group of patients without established renal dysfunction, there was no significant difference in levels of serum Cys C between patients with unstable plaque and patients with no lesions.The prevalence of physical exercise in patients with carotid plaque was lower than the patients with no lesions in different kidney function. The plaque burden between stable plaque and unstable plaque group has no significant difference. The detailed results were shown in Table 1 . Table 2 showed that Cys C was not only a risk factor for stable plaque, but also was a risk factor for unstable plaque in patients with mild decreased GFR.. However, among patients with normal GFR, serum Cys C was only a risk factor for stable plaque but not for unstable plaque (Figure 1, 2) .
Influencing factors of carotid plaque phenotype
The correlation analysis between plaque burden and serum Cys C
Smoothing function curve analysis suggested a nonlinear relationship between Cys C and plaque area and Crouse score adjusting for age, sex, serum LDL and HDL (Figure 1-2) . A three-piecewise linear regression showed that the plaque score and plaque area tended to increase regardless of the status of renal function while serum Cys C floated in the range of 0.75-1.29 (mg/L), (Correction factors according to the results of multivariate logistic regression) (Table 3) . on [26, 27] . Detailed mechanism of the linkage between Cys C and carotid artery lesions has not been fully elucidated. Renal mechanism seems to be a plausible link between increased Cys C and CVD. It has been widely recognized that cardiovascular events frequently occur in patients with chronic kidney disease (CKD) [28, 29] . Renin-angiotensin-aldosterone system (RAAS) plays a key role in the process of CKD. Serum Cys C was assumed to be a sensitive indicator of "pre-clinical" renal disease which can not be detected by GFR based on serum Cr [30] . Serum Cys C was identifies mild renal dysfunction. There is increased activation of the RAAS system with potentially deleterious effects. 
Discussion
In this study, our results suggested that, among patients with mild impaired renal function, Cys C levels were associated carotid artery lesions. In routine clinical practice, GFR valueis usually estimated based on the circulating concentration of an endogenous marker, such as creatinine, due to the infeasibility of direct measurement of actual GFR value. Cys C has emerged as a highly sensitive marker of even mildly impaired GFR [24, 25] . Indeed, because of its small size (13 kDa), Cys-C is freely filtred by the glomerulus and neither secreted nor reabsorbed by tubular epithelial cells of kidneys. A reduced GFR is a strong independent predictor of all-cause and cardiovascular mortality, and is considered as a cardiovascular risk, as well as a indicator of previous history of myocardial infarcti-Interestingly, a few recent studies reported consistent findings showing that cardiovascular risk starts increasing for GFR still within the normal range [31] . In this study, we demonstrated that Cys C was a risk factor of stable plaque, and the increased level of serum Cys C may benefit to the stability of plaques in patients with normal renal function. Rupture of the cap of atherosclerotic plaques is considered to be a crucial step in the development of myocardial infarction and stroke [32, 33] . Sudden alterations in atherosclerotic plaque structure such as cap rupture and intra plaque hemorrhage frequently precede ischemic Table 2 . The analysis of Cys C effect on plaque phenotype by multinomial logistic regression in different status of kidney function Fig. 1 . The relationship between Cys C (mg/L) and Crouse score and their 95% confidence intervals (shade scope) in patients with normal renal function (solid line, factor "1"= normal renal function) and in patients with mild impaired renal function (dashed line, factor "2"= mild impaired renal function), which using generalized smoothing splines with 5 knots. When serum cystatin C was in the range of 0.75-1.30 (mg/L), the Crouse score tended to increase, and their 95% confidence intervals less volatile. A: no adjusted; B: adjusted for age, sex, serum LDL and HDL. cardiovascular events. It has been suggested that plaque rupture is caused by a localized imbalance in proteolytic activity, and of particular interest is the family of enzymes known as the matrix metalloproteinases and cathepsin [34, 35] . The cap of the plaque is composed predominantly of type III collagen [36] . Collagen is synthesized by smooth muscle cells (SMCs). Thus, increased collagen and elastic fibers could result from an increased number of SMCs or increased extracellular matrix synthesis by these cells. Cys C is a member of the cystatin superfamily of endogenous cysteine protease inhibitors that inhibits the protease of cathepsin and which is produced by all nucleated cells. The dynamic unbalance of cathepsin and its inhibitor-Cys C was the main reason leading to extracellular matrix remodeling. However, the dynamic balance of formation and degradation in ECM plays a key role in the development and progression of plaque phenotype. Normal physiological remodeling allows the adult blood vessel to adapt and repair, whereas perturbation of vascular remodeling is an important component of the pathogenesis of atherosclerosis, plaque rupture, restenosis, and aneurysm formation. Overexpression of matrix metalloproteinase and cysteine protease, known as cathepsins, also has been implicated in atherosclerosis, and the potential Table 3 . Threshold effect analysis of serum Cys C on plaque burden using linear regression ) and their 95% confidence intervals (shade scope) in patients with normal renal function (solid line, factor "1"= normal renal function) and in patients with mild impaired renal function (dashed line, factor "2"= mild impaired renal function), which using generalized smoothing splines with 5 knots. When serum cystatin C was in the range of 0.75-1.30 (mg/L), the plaque area tended to increase, and their 95% confidence intervals less volatile. C: no adjusted; D: adjusted for age, sex, serum LDL and HDL.
significance of imbalance between cysteine proteases and their most abundant inhibitor-Cys C has been highlighted by the demonstration of Cys C deficiency in acute myocardial infarction [37] . Previous studies have revealed that the severe depression of cystatin C antigen levels within SMCs of atherosclerotic plaques and which implied a marked change in the functional properties of plaque SMC [38] . Deo R et al. have also revealed that the elevated levels of Cys C were associated with inducible ischemia among outpatients with stable coronary disease [39] .
Additionally, in this study we also demonstrate that a nonlinear relationship was observed between serum Cys C and plaque burden after adjusted for age, sex, serum LDL and HDL. When serum Cys C was in the range of 0.75-1.30 (mg/L), the plaque burden tended to increase. In an early state of CAS, LDL accumulates in the intimal layer in blood vessels. Oxidation of the LDL induces recruitment of inflammatory cells, such as bone marrowderived monocytes and T lymphocytes [40] . Later, SMCs from the media migrate through the internal elastic laminae, and abnormal proliferation. The abnormal proliferation of SMCs expresses abundant collagen, especially in the development and progression of CVD, and forms a thickly and elastic fibrous cap over a core of lipids, inflammatory and necrotic cells [40] . Cys C is a member of the cystatin superfamily of endogenous cysteine protease inhibitor and which can inhibit the degradation of ECM [41] . The ECM of the vessel wall is composed of collagen, elastin, proteoglycans and a number of other glycoproteins. Both elastin and collagen are important structural proteins, forming plaque fibrous cap and giving elastic and tensile properties to ECM [42] . Gu F et al. have revealed that serum cystatin C positively correlated with plaque area (r=0.467, P <.001) and plaque burden (r=0.395, P=.003) in patients with unstable angina [43] . Silva D et al. also found that a high baseline Cys C level was associated with an increased risk of death (OR=8.50; P<.001) and death or reinfarction (OR= 3.89; P=.02) [44] . Our findings are also in line with those by Niccoli et al, who found that cystatin C independently predicted coronary atherosclerotic burden and long-term prognosis [45] .
This study has several limitations. First, this was a human-based study, we have found a phenomenon that a nonlinear relationship was observed between serum Cys C and plaque burden and the serum Cys C was in the range of 0.75-1.30 (mg/L), the plaque burden tended to increase. However, animal experiments were not carried out to explore the detailed mechanisms. In the future study, we will establish animal model to explore the causal relationship of them. Secondly, we used MDRD formula to estimate the renal function. The accuracy of renal function evaluation could be improved by applying actual GFR measurements in future studies.
Conclusion
Serum Cys C may benefit to the stability of plaques among patients with normal kidney function. Within a certain range, serum Cys C is associated with an increased carotid plaque burden.
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